(Q36286200)

13 August 2017

1 reference

title

Treatment of epidermal necrolysis with high-dose intravenous immunoglobulins (IV Ig): clinical experience to date (English)

1 reference

13 August 2017

Ousmane Faye

1

1 reference

13 August 2017

Jean-Claude Roujeau

series ordinal

2

1 reference

13 August 2017

language of work or name

1 reference

1 January 2005

1 reference

13 August 2017

1 reference

13 August 2017

65

1 reference

13 August 2017

15

1 reference

13 August 2017

2085-2090

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200565150-00002

13 August 2017

0 references

cites work

Toxic epidermal necrolysis treated with intravenous high-dose immunoglobulins: our experience

1 reference

12 December 2020

Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells.

1 reference

12 December 2020

Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin.

1 reference

12 December 2020

Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin

1 reference

12 December 2020

Toxic epidermal necrolysis: does immunoglobulin make a difference?

1 reference

12 December 2020

Toxic epidermal necrolysis and Stevens-Johnson syndrome. An epidemiologic study from West Germany

1 reference

12 December 2020

Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme

1 reference

12 December 2020

Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis

1 reference

12 December 2020

SCORTEN: a severity-of-illness score for toxic epidermal necrolysis

1 reference

12 December 2020

Intravenous immunoglobulin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis: a prospective noncomparative study showing no benefit on mortality or progression

1 reference

12 December 2020

Effect of high-dose intravenous immunoglobulin therapy in Stevens-Johnson syndrome: a retrospective, multicenter study.

1 reference

12 December 2020

High-dose intravenous immunoglobulin for severe drug reactions: efficacy in toxic epidermal necrolysis

1 reference

12 December 2020

Analysis of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis using SCORTEN: The University of Miami Experience

1 reference

12 December 2020

Intravenous immunoglobulin does not improve outcome in toxic epidermal necrolysis

1 reference

12 December 2020

Use of SCORTEN to accurately predict mortality in patients with toxic epidermal necrolysis in the United States

1 reference

12 December 2020

Treatment of toxic epidermal necrolysis with high-dose intravenous immunoglobulins: multicenter retrospective analysis of 48 consecutive cases

1 reference

12 December 2020

Severe adverse cutaneous reactions to drugs

1 reference

12 December 2020

Unusual Spindle Cell Squamous Carcinoma in a Renal Transplant Patient

1 reference

12 December 2020

10.2165/00003495-200565150-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

13 August 2017

0 references

1 reference